Multiple bacterial and viral antigens

The term **multiple bacterial and viral antigens** does not refer to a single, well-defined molecular target but rather to a broad and heterogeneous set of molecules present on the surface of bacteria and viruses that are recognized by the immune system. Antigens are substances (typically proteins, glycoproteins, or polysaccharides) capable of inducing an immune response, including the production of antibodies or activation of T cells. Each bacterial or viral species typically expresses multiple unique antigens that may be used for serotyping, diagnosis, or as immunogens in vaccines. Because the phrase lumps together innumerable, structurally diverse molecules, it is not considered correct or useful as a precise drug, vaccine, or diagnostic target, and is not a canonical molecular target in biomedical research or clinical therapeutics. **Note on correctness:** This entry is *not* a singular, scientifically recognized therapeutic target. Scientifically, every bacterial or viral antigen is separate and must be individually specified when discussing targets for drugs, vaccines, or antibodies. “Multiple bacterial and viral antigens” is an imprecise and non-canonical term in this context.

Elicitation of immune response (antibodies, T cells) when presented in vaccine, diagnostic, or experimental settings.